[REDUCTION OF THE PLASMA CONCENTRATION OF THE CHARLOTTE FRIEND LEUKEMOGENIC VIRUS BY ADOPTIVE IMMUNOTHERAPY (GRAFT OF ALLOGENIC BONE MARROW)].
D001853:Bone Marrow; D016026:Bone Marrow Transplantation; D005622:Friend murine leukemia virus; D033062:Friends; D016219:Immunotherapy, Adoptive; D007938:Leukemia; D009052:Leukemia Virus, Murine; D007942:Leukemia, Experimental; D051379:Mice; D009369:Neoplasms / Q000276:immunology*; D009858:Oncogenic Viruses; D011830:Radiation Effects / Q000276:immunology*; D012106:Research; D012190:Retroviridae; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
BONE MARROW TRANSPLANTATION; EXPERIMENTAL LAB STUDY; LEUKEMIA, EXPERIMENTAL; MICE; MOUSE LEUKEMIA VIRUSES; NEOPLASM IMMUNOLOGY; ONCOGENIC VIRUSES; RADIATION EFFECTS; RADIATION IMMUNOLOGY; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS
R'EDUCTION DE LA CONCENTRATION PLASMATIQUE DU VIRUS LEUC'EMIG'ENE DE CHARLOTTE FRIEND PAR IMMUNOTH'ERAPIE ADOPTIVE (GREFFE DE MOELLE OSSEUSE ALLOG'ENIQUE.